Claims for Patent: 6,365,405

Summary for Patent: 6,365,405

Title:	Compositions of chondrocytes, preparation and utilization
Abstract:	This invention concerns compositions of chondrocytic cells, notably human ones, and the methods for preparing and using them. More specifically, the invention describes the production of autologous human chondrocyte suspensions, employing recombinant enzymes and/or media that are compatible with pharmaceutical use. The invention also describes methods and compositions for freezing chondrocytes, notably in the absence of DMSO. The chondrocytes which are produced can be used in vivo to restore affected cartilaginous structures, such as in post-traumatic cartilaginous defects or dissecting osteochondrite of the knee or, more generally, for treating and repairing clinically significant defects in cartilage, notably in joint cartilage.
Inventor(s):	Salzmann; Jean-Loup (Paris, FR), Crespo; Andres (Ormesson sur Marne, FR), Klatzmann; David (Paris, FR), Passuti; Norbert (Saint Sebastien sur Loire, FR)
Assignee:	Universite Pierre et Marie Curie (Paris IV) (Paris, Cedex, FR)
Application Number:	09/662,469
Patent Claims:	1. A method of producing a chondrocyte preparation from a biological sample, said method comprising: a) treating the biological sample in the presence of a recombinant enzyme capable of dissociating chondrocytes contained in said biological sample, b) monolayer culturing chondrocytes thus dissociated, and c) contacting the chondrocytes with a medium comprising at least one polyosidic derivative compound, in order to detach adhering chondrocytes. 2. The method according to claim 1, further comprising the following stages: d) optionally, repeating stages b) and c) once or several times, and e) recovering the cells produced. 3. The method according to claim 1, further comprising stage f) consisting of freezing the chondrocytes obtained. 4. The method according to claim 3, wherein freezing is performed in a DMSO medium. 5. The method according to claim 1, wherein the biological sample is a fragment of cartilaginous tissue or marrow, or of any other biological material comprising chondrocytes. 6. The method according to claim 5, wherein the biological sample is a fragment of cartilage. 7. The method according to claim 6, wherein the biological sample is a fragment of joint cartilage. 8. The method according to claim 6, wherein the biological sample is maintained in a culture containing a nutritive medium, either prior to or concomitant with stage a). 9. The method according to claim 1, wherein, in stage a), the biological sample is treated in the presence of a recombinant collagenase. 10. The method according to claim 9, wherein the recombinant collagenase is a recombinant bacterial collagenase or a recombinant mammalian collagenase. 11. The method according to claim 1, wherein, in stage c), the polyosidic derivative is a polyosidic polymer. 12. The method according to claim 11, wherein, in stage c), the polyosidic derivative is a polysaccharide. 13. The method according to claim 11, wherein the polyosidic derivative is selected from heparin and dextran sulfate. 14. The method according to claim 1, wherein said chondrocytes are human chondrocytes. 15. The method according to claim 14, wherein said preparation of human chondrocytes is a suspension of autologous human chondrocytes. 16. The method according to claim 14, wherein said preparation of human chondrocytes is an artificial cartilage produced in vitro. 17. The method according to claim 16, further comprising a stage in which the chondrocytes obtained are cultured on a synthetic matrix, or into a support device that has a non-adherent surface. 18. A composition comprising chondrocytes obtained by a method according to claim 1. 19. A method of producing a suspension of human chondrocytes, said method comprising: a) treating a cartilaginous tissue in the presence of a recombinant collagenase capable of dissociating chondrocytes contained in said tissue, b) monolayer culturing chondrocytes thus dissociated, c) contacting the chondrocytes with a medium comprising at least one polysaccharide compound, in order to detach adhering chondrocytes, d) optionally, repeating stages b) and c) once or several times, e) recovering the suspension of cells produced, and f) freezing the chondrocytes suspension obtained.

Details for Patent 6,365,405

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2019-09-16